Suchergebnisse - "Ghirardi, Valentina"

PubPharm (34)

1

Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy : A Prospective Analysis on Perioperative and Oncologic Outcomes

enthalten in: Annals of surgical oncology | 2024

von Ghirardi, V. | Trozzi, R. | Scanu, F. | +8

2

ASO Visual Abstract : Expanding the Use of HIPEC in Ovarian Cancer at the Time of Interval Debulking Surgery to FIGO Stage IV After Six Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis of Perioperative and Oncologic Outcomes

enthalten in: Annals of surgical oncology | 2024

von Ghirardi, V. | Trozzi, R. | Scanu, F. | +8

3

Current and future trials about HIPEC in ovarian cancer

enthalten in: Bulletin du cancer | 2024

von Ghirardi, V. | Trozzi, R. | Scambia, G. | +1

4

ASO Author Reflections : Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking Surgery

enthalten in: Annals of surgical oncology | 2024

von Ghirardi, V. | Trozzi, R. | Scambia, G. | +1

5

Expanding the Use of HIPEC in Ovarian Cancer at Time of Interval Debulking Surgery to FIGO Stage IV and After 6 Cycles of Neoadjuvant Chemotherapy: A Prospective Analysis on Perioperative and Oncologic Outcomes

enthalten in: Annals of surgical oncology | 2024

von Ghirardi, V. | Trozzi, R. | Scanu, F. | +8

6

Hyperthermic intraperitoneal chemotherapy for ovarian cancer : long-term findings from the OVHIPEC-1 trial

enthalten in: The Lancet. Oncology | 2023

von Ghirardi, V. | Fagotti, A. | Scambia, G.

CommentOn: Lancet Oncol. 2023 Oct;24(10):1109-1118. - PMID 37708912

7

Enhanced Recovery after Surgery (ERAS) Program for Patients with Peritoneal Surface Malignancies Undergoing Cytoreductive Surgery with or without HIPEC : A Systematic Review and a Meta-Analysis

enthalten in: Cancers | 2023

von Robella, M. | Tonello, M. | Berchialla, P. | +12

8

Diagnostic and Therapeutic Pathway of Advanced Ovarian Cancer with Peritoneal Metastases

enthalten in: Cancers | 2023

von Ghirardi, V. | Fagotti, A. | Ansaloni, L. | +12

9

A Laparoscopic Adjusted Model Able to Predict the Risk of Intraoperative Capsule Rupture in Early-stage Ovarian Cancer : Laparoscopic Ovarian Cancer Spillage Score (LOChneSS Study)

enthalten in: Journal of minimally invasive gynecology | 2022

von Ghirardi, V. | De Felice, F. | Rosati, A. | +5

10

Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer : Is BRCA mutational status making the difference?

enthalten in: Cancer treatment and research communications | 2022

von Ghirardi, V. | De Felice, F. | D'Indinosante, M. | +4